StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Medexus Pharmaceuticals Inc.
Toronto Stock Exchange:MDP.TO
Sector
Location
Market Cap
USD 69.01 M
Share Price
USD 2.14
Avg Daily Volume
38,563
Change (1 day)
-4.49%
Change (1 year)
23.12%
Change (YTD)
-11.03%
Medexus Pharmaceuticals Inc. EBITDA for the year ending March 31, 2025: USD 16.81 M
Medexus Pharmaceuticals Inc. EBITDA is USD 16.81 M for the year ending March 31, 2025, a -12.78% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Medexus Pharmaceuticals Inc. EBITDA for the year ending March 31, 2024 was USD 19.28 M, a 19.44% change year over year.
-
Medexus Pharmaceuticals Inc. EBITDA for the year ending March 31, 2023 was USD 16.14 M, a 6.44% change year over year.
-
Medexus Pharmaceuticals Inc. EBITDA for the year ending March 31, 2022 was USD 15.16 M, a -164.23% change year over year.
-
Medexus Pharmaceuticals Inc. EBITDA for the year ending March 31, 2021 was USD -23.61 M, a -2,046.91% change year over year.
Competitors
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Haleon plc
USD 4.95
HLN.L
-0.10
-1.95%
Daiichi Sankyo Company, Limited
USD 22.09
4568.T
+0.15
0.69%
Ucb S.A.
USD 199.81
UCB.BR
-2.13
-1.05%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Haleon plc
USD 4.95
HLN.L
-0.10
-1.95%
Daiichi Sankyo Company, Limited
USD 22.09
4568.T
+0.15
0.69%
Ucb S.A.
USD 199.81
UCB.BR
-2.13
-1.05%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%